Search Results
Results found for "cAM SINH LU"
- Dr. GPCR Team | Dr. GPCR Ecosystem
During that time, I investigated the effect of lung cancer-related mutations in the GAIN domain of the Since beginning her undergraduate studies, she has used computational methods like molecular dynamics GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash Cam Sinh Lu on the web LinkedIn Dr. GPCR Unlock the Full Dr.
- Yao Lu (Jackie) | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Yao Lu (Jackie) About Yao Lu (Jackie) "Jackie is a Ph.D. small molecules for their pre-clinical efficacy and to support the design of novel therapeutics. " Yao Lu
- Dr. Lukas Grätz | Dr. GPCR Ecosystem
Lukas Grätz About Dr. Lukas Grätz "After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since In my free time I like to play the guitar, sing and play board games. " Dr. Lukas Grätz on the web Karolinska Institutet ResearchGate PubMed Dr. GPCR Unlock the Full Dr.
- Gáspár Pándy-Szekeres | Dr. GPCR Ecosystem
My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since In my free time I like to play the guitar, sing and play board games. " Gáspár Pándy-Szekeres on the
- Dr. Pierre Eftekhari | Dr. GPCR Ecosystem
development. have been engaged in GPCR cellular and clinical pharmacology as scientist or PI in neonatal lupus Since the creation of Inoviem scientific in Nov. 2011 by myself we have been regularly working with GPCRs
- Fluorescent Probes for GLP-1R and GIPR Imaging: From Cell Assays to In Vivo Systems | Dr. GPCR Ecosystem
LUXendin Family Red and far-red fluorescent GLP-1R antagonists derived from Exendin4(9–39). Since 2020, he leads an independent research group at the FMP Berlin. He is a principal architect of the LUXendin and daLUXendin probe families. Dr.
- Dr. Oliver Hartley | Dr. GPCR Ecosystem
Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
Since then, he has been studying the allosteric modulation and activation mechanism of this family of
- Julia Gardner | Dr. GPCR Ecosystem
Julia has been working as a researcher in Duke's Rajagopal Lab since her first year as an undergraduate
- Dr. Terry Kenakin | Dr. GPCR Ecosystem
Since 2011, Terry works at the Department of Pharmacology at the University of North Carolina School
- Chloe Hicks | Dr. GPCR Ecosystem
She has been an undergraduate student member in the Rajagopal Lab since January 2021 and has contributed
- Brendan Wilkins | Dr. GPCR Ecosystem
Since then, Brendan worked as a research assistant at the Victor Chang Cardiac Research Institute where
- Recombinant Antibodies for GPCRs: A Challenge to the Community | Dr. GPCR Ecosystem
Ball has been with GeneTex since 2012 and leads the company's enhanced antibody validation initiative Since 2020, its recombinant monoclonal antibody facility has produced reagents paired with enhanced validation
- Scott Struthers | Dr. GPCR Ecosystem
Scott Struthers, Ph.D., is our co-founder and has served as our President and Chief Executive Officer since
- Dr. Nicholas Holliday | Dr. GPCR Ecosystem
Since 2019, Nick has combined his university role with the leadership of Excellerate Bioscience as Chief
- Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem
Aylin Hanyaloglu has been a Principal Investigator at Imperial College London since 2007.
- Jennifer Pluznick: Olfactory Receptors in the Kidney and the Gut-Microbe Signal | Dr. GPCR Ecosystem
Instead, she followed it, and the decision has shaped the direction of her lab at Johns Hopkins ever since Matsunami's RTP1S chaperone, the Rho tag, and the Pluznick lab's Lucy tag — a cleavable leucine-rich kidney 19:56 The orthology problem: 1,000 mouse ORs, 350 human ones 23:08 RTP1S, the Rho tag, and the Lucy
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
Biochemistry and first came across GPCRs, particularly the receptor family I have been investigating ever since
- Murat Tunaboylu & Ben Holland | Dr. GPCR Ecosystem
learning for nearly 10 years, applying it to antibody generation, analysis, and property prediction since
- Dr. Rosie Dawaliby | Dr. GPCR Ecosystem
And since then, my incredible adventure as CEO of this fast-growing company started and is continuing
- Dr. Robert F. Bruns | Dr. GPCR Ecosystem
After 7 years at WL/PD and 26 years at Eli Lilly & Co., he retired at the end of 2014 and since then
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
Since my undergraduate studies, I have been engaged in researching molecular mechanisms that govern human
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
His group contributed to the early cloning of GPCRs in the mid-1980s and has since pushed the boundaries An MD-PhD who has practiced machine learning since 1989, he built Pharos, the public-facing data platform I have learned a lot since." — Dr. Tudor Oprea "Dan Rich worked on HIV protease inhibitors.
- Dr. Claudia Stäubert | Dr. GPCR Ecosystem
This fascination accompanied me and repeatedly challenged me ever since. Since 2014, I have led a research group at the Rudolf Schönheimer Institute of Biochemistry in Leipzig
- Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem
About this episode GPCRs have played a central role in my scientific career ever since I took Dr. Alexander Hauser , and Luise Wagner .
- Dr. Nyla Naim, Dr. Michael Lemieux & Dr. Jason Nasse | Dr. GPCR Ecosystem
Since then I transitioned into a Scientific Support role to leverage my passion for helping people!
- Dr. Raul Gainetdinov | Dr. GPCR Ecosystem
Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
around biased agonism principles received regulatory approval, but its actual functional selectivity has since In 2018 he joined the University of Copenhagen, where he has received an ERC Starting Grant, Lundbeck




























